Eurovestech
Venture Capital
Active
London, United Kingdom
9
3M
7
0.41
2
0.22
2
- Stages of investment
- Areas of investment
Summary
Eurovestech appeared to be the VC, which was created in 2000. The main office of represented VC is situated in the London. The company was established in Europe in United Kingdom.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Eurovestech, startups are often financed by Scottish Equity Partners, Wilmington Pharmatech, StartUp Health. The meaningful sponsors for the fund in investment in the same round are Intermountain Healthcare, Healthbox, Tencent Holdings. In the next rounds fund is usually obtained by Tencent Holdings, Scottish Equity Partners, Intermountain Healthcare.
Among the most successful fund investment fields, there are Health Care, Oil and Gas. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight ARKeX, Audionamix, Tute Genomics.
Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Eurovestech performs on 7 percentage points less the average number of lead investments. The high activity for fund was in 2007. The fund is constantly included in less than 2 deals per year. Deals in the range of 1 - 5 millions dollars are the general things for fund. The top amount of exits for fund were in 2016.
The fund was created by Richard Bernstein.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 2
- Exits
- 2
- Rounds per year
- 0.41
- Follow on index
- 0.22
- Investments by industry
- Software (7)
- Information Technology (3)
- Travel (2)
- Genetics (2)
- Biotechnology (2) Show 13 more
- Investments by region
-
- United Kingdom (4)
- United States (2)
- France (2)
- Israel (1)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 17
- Group Appearance index
- 0.44
- Avg. company exit year
- 6
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Tute Genomics | 16 Jun 2015 | Biotechnology, Software, Health Care, Genetics | Early Stage Venture | 3M | Utah, United States, Provo |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.